| abstract |
The present invention relates to modified Factor VII polypeptides that exhibit increased resistance to antithrombin inactivation and enhanced proteolytic activity. The invention also relates to polynucleotide constructs encoding such polypeptides, vectors and host cells, pharmaceutical compositions, uses and methods of treatment comprising and expressing such polynucleotides. |